Introduction
Hepatitis C virus (HCV) affects an estimated 3% of the world population and is the leading cause of liver-associated morbidity 1, 2 . Evasion or attenuation of host mediated antiviral responses results in chronic infection, liver cirrhosis and hepatocellular carcinoma 3 . The current combination therapy of IFN-α and ribavirin for chronic Hepatitis C has proven only partly successful. Viral clearance depends on the viral genotype, stage of the infection and only 50% of patients achieve the desired sustained antiviral response.
The HCV genome is a 9.6-kilobase uncapped, linear, single-stranded positive-sense RNA with an inherent ability to trigger innate antiviral responses. The molecular patterns of HCV result in the induction of type I IFN through RIG-I signaling [4] [5] [6] . IFNs are known to suppress HCV replication in vitro, by the induction of antiviral responses through activation of interferon stimulated genes (ISGs). Secreted type I IFNs bind to a heterodimeric IFN receptor (IFNAR). IFNAR activation and the subsequent phosphorylation of STAT1 and STAT2 results in interaction with IRF-9 and to the induction of ISGs that execute the establishment of an antiviral state 7 . One such target, IRF-7, responds to IFN stimulation by phosphorylation and induces IFNαs, leading to an amplification of the IFN response.
Given the critical role of innate immune responses in inhibiting HCV replication, it is not surprising that a number of factors of the IFN circuits (like MAVS, TRIF and STAT1) are actively counteracted [8] [9] [10] [11] or manipulated 12 by viral proteins. The existence of these viral mechanisms resulted in the evolution of redundant pathways for detection and inhibition of viral infections 13 . Interferon-independent signaling following peroxisomal activation of MAVS has been shown to induce an immediate albeit transient induction of an innate immune response 14 . In this study, we investigated the impact of IFN-dependent and IFN-6 independent actions on restriction of HCV replication. Our data acknowledge the functional role of interferon regulatory factors that interfere with viruses, independent of type I interferons.
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Material and Methods
Cell culture
STAT1
-/-and PKR -/-mouse embryonic fibroblasts (MEFs) were kindly provided by T.
Decker (University of Vienna, Austria) and C. Weissmann (University of Zürich, Switzerland .
To obtain mouse primary hepatocytes, 6-8 week-old mice were anesthetized with 0.1ml/10g body mass of ketamine (10%) xylazine (5%). Liver perfusion medium (17701038, Life technologies) supplemented with heparin (500U/ml) was injected into the vena cava followed by liver digest medium (17703-034, Life technologies) supplemented with collagenase H (55mg/150ml, Roche). The digested liver was excised and hepatocytes were released from the liver. Cells were passed through a 100 µm mesh. The cell suspension was centrifuged at 300 rpm for 5 minutes and the pellet washed. Total hepatocyte numbers were seeded in the desired concentration on collagen R-coated (47254.02, Serva) plastic. Cells were cultured in Dulbecco´s Modified Eagle Medium (Invitrogen) supplemented with 2 mM L-glutamine, nonessential amino acids, 100 U/ml of penicillin, 100 µg/ml of streptomycin, and 10% fetal calf serum.
Oligos encompassing the sequence of miR-122 (5´TGGAGTGTGACAATGGTGTTTG3´)
were cloned into S-miR-30-IEW vector
16
. The miR-RNA-lentiviral vector encodes for the miR-RNA followed by an IRES element and the gene that encodes for enhanced green fluorescent protein (eGFP). Infected cells were sorted for GFP expression. Type I IFNs 8 were neutralized by treating cells with 2 µg/ml of anti-IFNα (4EA1) and anti-IFN-β (7FD3)
antibodies neutralizing 250U of IFN.
In vitro transcription and electroporation
The generation of in vitro transcripts from WT JFH1 and the replication-deficient NS5B-inactive JFH1ΔGDD has been described elsewhere [17] [18] [19] . Following electroporation, cells were immediately transferred to 10 ml DMEM and 1 ml of the cell suspension was seeded per well in 12 well plates.
Luciferase reporter assay
Cell lysates were prepared at the indicated time points after electroporation using Passive Lysis Buffer according to manufacturer's instructions (E1941, Promega). Firefly luciferase was determined using a Luciferase Kit (Luciferase 1000 Assay System, Promega). All experiments were performed at least twice with triplicates before calculating mean values and standard deviations.
Western blot analysis and antibodies
For preparation of whole cell extracts, cells were lysed in buffer containing 250 mM Tris, 0.5% Triton X-100, and Halt protease inhibitor cocktail (Thermo Scientific Washed cover slips were subjected to staining with secondary goat antibodies specific to
IgG conjugated with Cy5 (Dianova) at a dilution of 1:800. Coverslips were mounted on a glass slide over a drop of Fluoroshield with DAPI (F6057, Sigma) and analyzed for fluorescence.
Transfection of primary hepatocytes
Transfection of primary hepatocytes was performed one day post isolation with 3 μg/ml RNA transcribed from subgenomic replicon JFH1 using Lipofectamine-2000 (Invitrogen)
according to manufacturer's instructions. Cells were lysed and luciferase signals were measure as described above.
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Results
The IFN system restricts HCV replication
To determine the role of the type I IFN system in the restriction of HCV replication we compared the replication of subgenomic genotype 2a strain (JFH1) luciferase replicon 25 in fibroblasts knocked-out for factors involved in induction, reaction and amplification of type I
IFNs as well as antiviral responses induced by alternative pathways. Replication of JFH1
has been described in mouse cells 26, 27 and HCV replication is enhanced by miR-122 in non-hepatic human and mouse cells 26, 28 . Conditionally immortalized 15 
IRFs mediate IFN-independent antiviral responses
The 
MAVS and IRF-1 are crucial restriction factors of HCV replication in hepatocytes
Since HCV is a hepatotropic virus, we decided to test if the IFN-independent responses observed in MEFs were equally active in hepatocytes. To this end, we transfected primary hepatocytes with JFH1 RNA in the absence or presence of type I IFN neutralizing antibodies and determined replication ( Figure 7A ). Replication was detectable in primary However, STAT1 -/-cells showed replication capacity comparable to IFNAR -/-cells, and thus significant contribution to and IFN-independent antiviral response has not to be assumed.
In addition, the absence of IRF-7 does not permit HCV replication indicating that the amplification of type I IFN response by IRF-7 is not important for controlling HCV replication.
PKR is an ISG and a direct role of PKR in the suppression of HCV RNA replication has been shown by over expression studies [41] [42] [43] . PKR -/-cells showed HCV replication but our data indicated that the extent of HCV replication is lower in comparison to that of IRF-3
and IFNAR -/-MEFs. The initial HCV replication followed by a subsequent decrease ( Figure   5 ) could be explained by a mechanism wherein HCV uses PKR to inhibit the IFN pathway at the translational level 44 .
Previous studies have shown antiviral responses of IRF-1 and IRF-5 45, 46 . hours post electroporation were used as read-out for transfection efficiency. Data
